Drug Profile
Siamycin 1
Alternative Names: BMY 29304; Siamycin ILatest Information Update: 15 Jul 2015
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Antibacterials; Antivirals
- Mechanism of Action HIV fusion inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 02 Sep 1998 No-Development-Reported for HIV infections treatment in USA (Unknown route)
- 22 May 1995 New profile
- 22 May 1995 Preclinical development for HIV infections treatment in USA (Unknown route)